North America Patient Controlled Injectors Market Growth and Forecast by 2027
North America Patient Controlled Injectors Market Forecast to 2027 - COVID-19 Impact and Regional Analysis by Product (Electronic Injectors, Mechanical Injectors, and Infusion Pumps); Application (Cancer Treatment, Auto-immune Treatment, Blood Disorders Treatment, and Others); Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Mail Order Pharmacies); and Country
- Report Date : Dec 2020
- Report Code : TIPRE00017288
- Category : Life Sciences
- Status : Published
- Available Report Formats :
- No. of Pages : 103
The North America patient controlled injectors market is expected to reach US$ 3,236.46 million by 2027 from US$ 1,261.43 million in 2019; it is estimated to grow at a CAGR of 12.6% from 2020 to 2027.
The increasing chronic diseases prevalence, and conventional drug delivery system limitations are the key factors driving the growth of patient controlled injectors. However, preference of alternative drug delivery may hinder the North America Patient Controlled Injectors market growth in North America.The patient-controlled injectors are the newest invention in the administration of injections. There are high-unmet needs of people/ HCPs or patients requiring the patient-controlled injectors as it has greater ease and comfort than any other auto-injectors. These are ergonomically developed, and design patient-controlled injectors can help optimize self-care, making it easy for patients to hold the system and administer the dosages at just one press.
Patient-controlled injectors are rapidly gaining their prominence in the market due to their ability to deliver a high volume of viscous formulations. In healthcare settings, the administration of medicines through an intravenous (IV) infusion is expensive. Moreover, self-administration of subcutaneous injections is expected to save 30–70% of costs. Higher dosage volumes and viscous formulations of these drugs are further emphasizing the need for alternative injection methods, such as wearable injectors. For instance, the SelfDose Patient-Controlled Injector manufactured by West Pharmaceutical Services, Inc. is designed to be ergonomic for optimal patient administration. Additionally, a safety system covers the needle before and after injection to prevent needle stick injuries to the patient and caregiver. Extensive trials of human factors have been carried out of the patient-controlled injector SelfDose, confirming the intuitive nature and encouraging its ease of use and patient acceptance.
A new category of products has emerged, bridging the gap between functionality and cost while improving patient safety and quality of life. One such example is Tremfya One-Press—a single-dose, patient-controlled injector, developed by Janssen Pharmaceutical Companies of Johnson & Johnson. The one-press design allows patients to control the rate and pressure of their injection. Moreover, continuous developments by leading players in upgrading the existing patient-controlled injector portfolio is further driving the demand for innovative patient-controlled injectors.
North America has been witnessing growing number of COVID-19 cases since its outbreak. For instance, according to Worldometer, the number of cases increased to 10,880,282 with 248,635 deaths reported in the US as of November 13, 2020. The cases are also increasing in Mexico and Canada. Several measures are being taken to contain the disease and prevent the transmission. Patients with severe health conditions, such as diabetes, immune diseases, cardiovascular, cancer, vascular needs physical distancing with others; however, delays in such chronic disease treatments is distressing. Therefore, it is likely to affect the patient controlled injectors market owing to the above mention points.
Mexico Patient Controlled Injectors Market, Revenue and Forecast to 2027 (US$ Mn)
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
NORTH AMERICA PATIENT CONTROLLED INJECTORS MARKET SEGMENTATION
By Product
- Electronic Wearable Injector
- Mechanical Wearable Injector
- Infusion Pumps
By Application
- Cancer Treatment
- Auto-immune Treatment
- Blood Disorders Treatment
- Others
By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Mail Order Pharmacies
By Country
- US
- Canada
- Mexico
Company Profiles
- Johnson and Johnson Services, Inc.
- West Pharmaceutical Services, Inc
- Enable Injections.
- scPharmaceuticals Inc
- United Therapeutics Corporation
- BD
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Product, Application, Distribution Channel, and Country
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
US, Canada
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 North America Patient Controlled Injectors Market – By Product
1.3.2 North America Patient Controlled Injectors Market – By Application
1.3.3 North America Patient Controlled Injectors Market – By Distribution Channel
1.3.4 North America Patient Controlled Injectors Market – By Country
2. North America Patient Controlled Injectors Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. North America Patient Controlled Injectors Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Patient Controlled Injectors Market - North America PEST Analysis
4.3 Expert Opinion
5. North America Patient Controlled Injectors Market - Key Market Dynamics
5.1 Key Market Drivers
5.1.1 Increasing Prevalence of Chronic Diseases
5.1.2 Rising Patient Compliance
5.2 Market Restraints
5.2.1 Preference of Alternative Drug Delivery
5.3 Market Opportunities
5.3.1 Technological Advancements and Design Development
5.4 Future Trends
5.4.1 Consolidation of Market
5.5 Impact Analysis
6. Patient Controlled Injectors Market – North America Analysis
6.1 North America Patient Controlled Injectors Market Revenue Forecasts and Analysis
7. North America Patient Controlled Injectors Market Analysis and Forecasts To 2027 – By Product
7.1 Overview
7.2 North America Patient Controlled Injectors Market, By Product 2019 & 2027 (%)
7.2.1 North America Patient Controlled Injectors Market Revenue and Forecasts to 2027, By Product (US$ Mn)
7.3 Electronic Injector
7.3.1 Overview
7.3.2 North America Electronic Injector Market Revenue and Forecast to 2027 (US$ Mn)
7.4 Mechanical Injectors
7.4.1 Overview
7.4.2 North America Mechanical Injectors Market Revenue and Forecasts to 2027 (US$ Mn)
7.5 Infusion Pumps
7.5.1 Overview
7.5.2 North America Infusion Pumps Market Revenue and Forecasts to 2027 (US$ Mn)
8. North America Patient Controlled Injectors Market Analysis – By Application
8.1 Overview
8.2 North America Patient Controlled Injectors Market, By Application 2019-2027 (%)
8.2.1 North America Patient Controlled Injectors Market Revenue and Forecasts to 2027, By Application (US$ Mn)
8.3 Cancer Treatment
8.3.1 Overview
8.3.2 North America Cancer Treatment Market Revenue and Forecasts to 2027 (US$ Mn)
8.4 Autoimmune Disease
8.4.1 Overview
8.4.2 North America Autoimmune Disease Market Revenue and Forecasts to 2027 (US$ Mn)
8.5 Blood Disorders Treatment
8.5.1 Overview
8.5.2 North America Blood Disorders Treatment Market Revenue and Forecasts to 2027 (US$ Mn)
8.6 Others
8.6.1 Overview
8.6.2 North America Others Market Revenue and Forecasts to 2027 (US$ Mn)
9. North America Patient Controlled Injectors Market Analysis – By Distribution Channel
9.1 Overview
9.2 North America Patient Controlled Injectors Market, By Distribution Channel 2019-2027 (%)
9.2.1 North America Patient Controlled Injectors Market Revenue and Forecasts to 2027, By Distribution Channel (US$ Mn)
9.3 Hospital Pharmacies
9.3.1 Overview
9.3.2 North America Hospital Pharmacies Market Revenue and Forecasts to 2027 (US$ Mn)
9.4 Retail Pharmacies
9.4.1 Overview
9.4.2 North America Retail Pharmacies Market Revenue and Forecasts to 2027 (US$ Mn)
9.5 Mail Order Pharmacies
9.5.1 Overview
9.5.2 North America Mail Order Pharmacies Market Revenue and Forecasts to 2027 (US$ Mn)
10. Patient Controlled Injectors Market Revenue and Forecasts To 2027 – Geographical Analysis
10.1 North America Patient Controlled Injectors Market Revenue and Forecasts To 2027
10.1.1 Overview
10.1.2 North America: Patient Controlled Injectors Market – Revenue and Forecast to 2027 (USD Million)
10.1.3 North America Patient Controlled Injectors Market, by Product– Revenue and Forecast to 2027 (USD Million)
10.1.4 North America Patient Controlled Injectors Market, by Application– Revenue and Forecast to 2027 (USD Million)
10.1.5 North America Patient Controlled Injectors Market, by Distribution Channel– Revenue and Forecast to 2027 (USD Million)
10.1.6 North America: Patient Controlled Injectors Market, by Country, 2019 & 2027 (%)
10.1.7 US: Patient Controlled Injectors Market – Revenue and Forecast to 2027 (USD Million)
10.1.7.1 US: Patient Controlled Injectors Market – Revenue and Forecast to 2027 (USD Million)
10.1.7.2 US Patient Controlled Injectors Market, by Product– Revenue and Forecast to 2027 (USD Million)
10.1.7.3 US Patient Controlled Injectors Market, by Application– Revenue and Forecast to 2027(USD Million)
10.1.7.4 US Patient Controlled Injectors Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
10.1.8 Canada: Patient Controlled Injectors Market – Revenue and Forecast to 2027 (USD Million)
10.1.8.1 Canada: Patient Controlled Injectors Market – Revenue and Forecast to 2027 (USD Million)
10.1.8.2 Canada Patient Controlled Injectors Market, by Products – Revenue and Forecast to 2027 (USD Million)
10.1.8.3 Canada Patient Controlled Injectors Market, by Application– Revenue and Forecast to 2027(USD Million)
10.1.8.4 Canada Patient Controlled Injectors Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
10.1.9 Mexico: Patient Controlled Injectors Market – Revenue and Forecast to 2027 (USD Million)
10.1.9.1 Mexico: Patient Controlled Injectors Market – Revenue and Forecast to 2027 (USD Million)
10.1.9.2 Mexico Patient Controlled Injectors Market, by Products – Revenue and Forecast to 2027 (USD Million)
10.1.9.3 Mexico Patient Controlled Injectors Market, by Application– Revenue and Forecast to 2027(USD Million)
10.1.9.4 Mexico Patient Controlled Injectors Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
11. Impact of COVID-19 Pandemic on North America Patient Controlled Injectors Market
11.1 North America: Impact Assessment of COVID-19 Pandemic
12. Company Profiles
12.1 West Pharmaceutical Services, Inc.
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Johnson and Johnson Services, Inc.
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Enable Injections
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 scPharmaceuticals Inc.
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 United Therapeutics Corporation
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 BD
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
13. Appendix
13.1 About the Insight Partners
13.2 Glossary of Terms
LIST OF TABLES
Table 1. North America Patient Controlled Injectors Market Revenue and Forecasts To 2027, By Product (US$ Mn)
Table 2. North America Patient Controlled Injectors Market Revenue and Forecasts To 2027, By Application (US$ Mn)
Table 3. North America Patient Controlled Injectors Market Revenue and Forecasts To 2027, By Distribution Channel (US$ Mn)
Table 4. North America Patient Controlled Injectors Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 5. North America Patient Controlled Injectors Market, by Application– Revenue and Forecast to 2027(USD Million)
Table 6. North America Patient Controlled Injectors Market, by Distribution Channel– Revenue and Forecast to 2027 (USD Million)
Table 7. US Patient Controlled Injectors Market, by Product– Revenue and Forecast to 2027 (USD Million)
Table 8. US Patient Controlled Injectors Market, by Application– Revenue and Forecast to 2027(USD Million)
Table 9. US Patient Controlled Injectors Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
Table 10. Canada Patient Controlled Injectors Market, by Products – Revenue and Forecast to 2027 (USD Million)
Table 11. Canada Patient Controlled Injectors Market, by Application– Revenue and Forecast to 2027(USD Million)
Table 12. Canada Patient Controlled Injectors Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
Table 13. Mexico Patient Controlled Injectors Market, by Products – Revenue and Forecast to 2027 (USD Million)
Table 14. Mexico Patient Controlled Injectors Market, by Application– Revenue and Forecast to 2027(USD Million)
Table 15. Mexico Patient Controlled Injectors Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
Table 16. Glossary of Terms, Patient Controlled Injectors Market
LIST OF FIGURES
Figure 1. Patient Controlled Injectors Market Segmentation
Figure 2. North America Patient Controlled Injectors Market Overview
Figure 3. Electronic Injector Segment Held Largest Share of Product in Patient Controlled Injectors Market
Figure 4. US is Expected to Show Remarkable Growth During the Forecast Period
Figure 5. North America Patient Controlled Injectors Market - Leading Country Markets (US$ Mn)
Figure 6. Patient Controlled Injectors Market - North America PEST Analysis
Figure 7. Patient Controlled Injectors Market Impact Analysis of Driver and Restraints
Figure 8. North America Patient Controlled Injectors market – Revenue Forecasts and Analysis – 2019- 2027
Figure 9. North America Patient Controlled Injectors Market, By Product 2019 & 2027 (%)
Figure 10. North America Electronic Injector Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 11. North America Mechanical Injectors Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 12. North America Infusion Pumps Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 13. North America Patient Controlled Injectors Market, by Application 2019 & 2027 (%)
Figure 14. North America Cancer Treatment Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 15. North America Autoimmune Disease Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 16. North America Blood Disorders Treatment Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 17. North America Others Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 18. North America Patient Controlled Injectors Market, by Distribution Channel 2019 & 2027 (%)
Figure 19. North America Hospital Pharmacies Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 20. North America Retail Pharmacies Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 21. North America Mail Order Pharmacies Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 22. North America: Patient Controlled Injectors Market, by Key Country – Revenue (2019) (USD Million)
Figure 23. North America Patient Controlled Injectors Market Revenue and Forecast to 2027 (USD Million)
Figure 24. North America: Patient Controlled Injectors Market, by Country, 2019 & 2027 (%)
Figure 25. US: Patient Controlled Injectors Market – Revenue and Forecast to 2027 (USD Million)
Figure 26. Canada: Patient Controlled Injectors Market – Revenue and Forecast to 2027 (USD Million)
Figure 27. Mexico: Patient Controlled Injectors Market – Revenue and Forecast to 2027 (USD Million)
Figure 28. Impact of COVID-19 Pandemic in North American Country Markets
- Johnson and Johnson Services, Inc.
- West Pharmaceutical Services, Inc
- Enable Injections.
- scPharmaceuticals Inc
- United Therapeutics Corporation
- BD
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For